Volz et al. conducted a retrospective analysis to find out more about the use of a proprietary lavender oil preparation over a longer period of time (>3 or >6 months) and to evaluate the usage behavior of 12-17-year-olds. For this purpose, they analyzed large data sets from Switzerland and Germany. The results are very informative and confirm the positive results of this widespread treatment option in a real-world setting.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- New perspectives for the optimization of cancer immunotherapy
Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9
- Past, present and future
Biomarkers in schizophrenia
- From genome profiles to targeted therapies
Advances in breast cancer therapy in the age of molecular diagnostics
- Current overview of evidence, mechanisms and clinical implications
Apolipoprotein E and neuropsychiatric symptoms in neurocognitive disorders
- Parkinson's disease
Individual therapy management for an optimized outcome – an update
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Latent autoimmune diabetes in adults (LADA)
Looks like type 2, but is type 1
- Treatment of vitiligo